Literature DB >> 10359303

Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level.

Bryon W Petschow1, Robert D Talbott1, Rosanne P Batema1.   

Abstract

Lactoferrin (Lf) is an iron-binding protein which has been shown to inhibit the growth of various bacterial pathogens and promote the growth of anaerobic bacteria of the genus Bifidobacterium in vitro. The present study was designed to investigate whether the bifidobacteria growth promotion activity of Lf is correlated with either the binding of Lf to bifidobacterial cells or the iron saturation of Lf. Bovine Lf (bLf) from mature milk increased the growth of B. infantis and B. breve in vitro in a dose-dependent fashion, while much less growth promotion activity was found for B. bifidum. In contrast, human Lf (huLf) from mature milk promoted the growth of B. bifidum and was inactive for B. infantis and B. breve, while bLf from colostrum was devoid of bifidobacteria growth promotion activity. Changes in the iron content of Lf did not alter the bifidobacteria growth promotion activity of either bLf or huLf preparations. Competitive binding studies with biotinylated milk bLf showed that binding of bLf was inhibited by unlabelled bLf and huLf but not by beta-lactoglobulin, alpha-lactalbumin or transferrin. Binding of bLf to B. bifidum and B. breve was c. 40-fold higher than binding to Escherichia coli. Colostrum bLf was also found to bind to B. bifidum and B. breve, despite a lack of in-vitro growth promotion activity. Collectively, these results demonstrate that the ability of Lf to promote the growth of Bifidobacterium spp. in vitro is independent of the iron saturation level for Lf and suggest that binding of Lf to bifidobacteria cells may be involved but is not sufficient for stimulation of bifidobacterial growth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359303     DOI: 10.1099/00222615-48-6-541

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  17 in total

1.  In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Diane Dryja; Allen Leavens; Ronald L Neiswander; Haiping Qiao; Douglas DiRienzo; Pearay Ogra
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

2.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Haiping Qiao; Diane Dryja; Allen Leavens; Jon Rossman; Gary Rich; Douglas Dirienzo; Pearay L Ogra
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

Review 3.  Breast milk oligosaccharides: structure-function relationships in the neonate.

Authors:  Jennifer T Smilowitz; Carlito B Lebrilla; David A Mills; J Bruce German; Samara L Freeman
Journal:  Annu Rev Nutr       Date:  2014-05-15       Impact factor: 11.848

4.  Endo-β-N-acetylglucosaminidases from infant gut-associated bifidobacteria release complex N-glycans from human milk glycoproteins.

Authors:  Daniel Garrido; Charles Nwosu; Santiago Ruiz-Moyano; Danielle Aldredge; J Bruce German; Carlito B Lebrilla; David A Mills
Journal:  Mol Cell Proteomics       Date:  2012-06-27       Impact factor: 5.911

5.  Oligosaccharides Released from Milk Glycoproteins Are Selective Growth Substrates for Infant-Associated Bifidobacteria.

Authors:  Sercan Karav; Annabelle Le Parc; Juliana Maria Leite Nobrega de Moura Bell; Steven A Frese; Nina Kirmiz; David E Block; Daniela Barile; David A Mills
Journal:  Appl Environ Microbiol       Date:  2016-05-31       Impact factor: 4.792

Review 6.  The impact of the milk glycobiome on the neonate gut microbiota.

Authors:  Alline R Pacheco; Daniela Barile; Mark A Underwood; David A Mills
Journal:  Annu Rev Anim Biosci       Date:  2014-11-05       Impact factor: 8.923

Review 7.  Human Milk Components Modulate Toll-Like Receptor-Mediated Inflammation.

Authors:  YingYing He; Nathan T Lawlor; David S Newburg
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

8.  Neolactoferrin as a stimulator of innate and adaptive immunity.

Authors:  A D Chernousov; M F Nikonova; N I Sharova; A N Mitin; M M Litvina; P E Sadchikov; I L Goldman; A A Yarilin; E R Sadchikova
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

9.  Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model.

Authors:  Yi-Chieh Li; Chang-Chi Hsieh
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

10.  Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial.

Authors:  William H Johnston; Claude Ashley; Michael Yeiser; Cheryl L Harris; Suzanne I Stolz; Jennifer L Wampler; Anja Wittke; Timothy R Cooper
Journal:  BMC Pediatr       Date:  2015-11-07       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.